104 related articles for article (PubMed ID: 7075589)
21. Refinement at 1.4 A resolution of a model of erabutoxin b: treatment of ordered solvent and discrete disorder.
Smith JL; Corfield PW; Hendrickson WA; Low BW
Acta Crystallogr A; 1988 May; 44 ( Pt 3)():357-68. PubMed ID: 3272151
[TBL] [Abstract][Full Text] [Related]
22. The 1H nuclear-magnetic-resonance spectra of Neurotoxin I and cardiotoxin Vii4 from Naja mossambica mossambica.
Lauterwein J; Lazdunski M; Wüthrich K
Eur J Biochem; 1978 Dec; 92(2):361-71. PubMed ID: 33043
[TBL] [Abstract][Full Text] [Related]
23. Proton-nuclear-magnetic-resonance study on molecular conformations of long neurotoxins. alpha-Bungarotoxin from Bungarus multicinctus and Toxin B from Naja naja.
Endo T; Inagaki F; Hayashi K; Miyazawa T
Eur J Biochem; 1981 Nov; 120(1):117-24. PubMed ID: 7308209
[TBL] [Abstract][Full Text] [Related]
24. Sequence analysis of a cDNA encoding a erabutoxin b from the sea-snake Laticauda semifasciata.
Obara K; Fuse N; Tsuchiya T; Nonomura Y; Ménez A; Tamiya T
Nucleic Acids Res; 1989 Dec; 17(24):10490. PubMed ID: 2602157
[No Abstract] [Full Text] [Related]
25. Immunological studies on erabutoxin b, a sea snake toxin. Attempts to locate the amino acid residues determining antigenicity.
Abe T; Tamiya N
Toxicon; 1979; 17(6):571-82. PubMed ID: 93322
[No Abstract] [Full Text] [Related]
26. The dynamic structures of proteins: short and long neurotoxins as examples.
Inagaki F; Miyazawa T; Williams RJ
Biosci Rep; 1981 Oct; 1(10):743-55. PubMed ID: 7030428
[No Abstract] [Full Text] [Related]
27. Narrowing the gap between experimental and computational determination of methyl group dynamics in proteins.
Hoffmann F; Xue M; Schäfer LV; Mulder FAA
Phys Chem Chem Phys; 2018 Oct; 20(38):24577-24590. PubMed ID: 30226234
[TBL] [Abstract][Full Text] [Related]
28. Tryptophan sidechain dynamics in hydrophobic oligopeptides determined by use of 13C nuclear magnetic resonance spectroscopy.
Weaver AJ; Kemple MD; Prendergast FG
Biophys J; 1988 Jul; 54(1):1-15. PubMed ID: 3416021
[TBL] [Abstract][Full Text] [Related]
29. Nuclear magnetic resonance spectrometric investigations of calcium antagonist drugs. III: Conformational and dynamic features of diltiazem in solution.
Gaggelli E; Maccotta A; Valensin G
J Pharm Sci; 1992 Apr; 81(4):367-70. PubMed ID: 1501076
[TBL] [Abstract][Full Text] [Related]
30. Solid-state 2H NMR study of methyl-d3-cobalamin.
Garbutt JR; Goward GR; Kirby CW; Power WP
Biochem Cell Biol; 1998; 76(2-3):423-8. PubMed ID: 9923711
[TBL] [Abstract][Full Text] [Related]
31. Proceedings: Structure studies of a sea snake neurotoxin "erabutoxin b".
Low BW
J Biochem; 1976 Apr; 79(4):27P. PubMed ID: 931962
[No Abstract] [Full Text] [Related]
32. Protein side-chain dynamics as observed by solution- and solid-state NMR spectroscopy: a similarity revealed.
Agarwal V; Xue Y; Reif B; Skrynnikov NR
J Am Chem Soc; 2008 Dec; 130(49):16611-21. PubMed ID: 19049457
[TBL] [Abstract][Full Text] [Related]
33. Preparation and activity of guanidinated or acetylated erabutoxins.
Hori H; Tamiya N
Biochem J; 1976 Feb; 153(2):217-22. PubMed ID: 1275885
[TBL] [Abstract][Full Text] [Related]
34. 1H and 13C NMR relaxation studies of molecular dynamics of the thyroid hormones thyroxine, 3,5,3'-triiodothyronine, and 3,5-diiodothyronine.
Duggan BM; Craik DJ
J Med Chem; 1996 Sep; 39(20):4007-16. PubMed ID: 8831766
[TBL] [Abstract][Full Text] [Related]
35. Biogenic antagonists of the nicotinic receptor: their interactions with erabutoxin.
Koketsu K; Akasu T; Miyagawa M; Hirai K
Brain Res; 1982 Nov; 250(2):391-3. PubMed ID: 6293646
[TBL] [Abstract][Full Text] [Related]
36. Tritium labeling of alpha-neurotoxins with N-succinimidyl[3H]propionate.
Sugiyama H; Yamashita Y
J Biochem; 1981 Sep; 90(3):729-35. PubMed ID: 7309696
[TBL] [Abstract][Full Text] [Related]
37. Solution conformation of cobrotoxin: a nuclear magnetic resonance and hybrid distance geometry-dynamical simulated annealing study.
Yu C; Bhaskaran R; Chuang LC; Yang CC
Biochemistry; 1993 Mar; 32(9):2131-6. PubMed ID: 8443154
[TBL] [Abstract][Full Text] [Related]
38. Comparison of refolding patterns of erabutoxin b and cardiotoxin 3.10.2 from snake venom.
Agbaji AS
Indian J Biochem Biophys; 1994 Feb; 31(1):20-3. PubMed ID: 8076968
[TBL] [Abstract][Full Text] [Related]
39. 1H- and 13C-n.m.r. studies of the antitumour antibiotic luzopeptin. Resonance assignments, conformation and flexibility in solution.
Searle MS; Hall JG; Wakelin PG
Biochem J; 1988 Nov; 256(1):271-8. PubMed ID: 3223903
[TBL] [Abstract][Full Text] [Related]
40. Correction of partial amino acid sequence of erabutoxins.
Maeda N; Tamiya N
Biochem J; 1977 Oct; 167(1):289-91. PubMed ID: 588261
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
